Effect of oral zinc sulfate in prevention of jaundice in healthy term newborns

Homa Babaei, Mitra Hemmati, Venoos Fallahi, Mansour Rezaei


Background: Jaundice is observed during the 1st week of life in approximately 60% of term infants. This study was aimed to evaluate the effect of oral zinc sulfate in prevention of jaundice in healthy term newborns.

Methods: In this clinical trial study, 124 healthy term infants with postnatal age less than 24 hours, that were born in Imam Reza Hospital (AS) in Kermanshah, were enrolled and equally divided into two groups, experimental and control (n=62). The infants in the control group only received the routine neonatal care without any intervention. In the treatment group, the newborns received 5 mg zinc sulfate 1% in a single dose daily for 5 days. In both groups, transcutaneous bilirubin was daily measured by bilimeter. Data were analyzed by statistical methods.

Results: The mean frequency of stools in the treatment and control groups were 2.02±1.20 and 1.08±0.946, respectively in the first day and 3.76±1.38 and 2.81± 0.674 in the fifth day, which indicated a significant difference between the two groups (P<0.001). Transcutaneous bilirubin level in the first and second day after birth revealed no significant difference between the two groups, but it decreased in the treatment group from the third to fifth day indicating a statistically significant difference compared to control group (P<0.05).

Conclusion: Preventive oral administration of 5 mg of zinc sulfate per day to healthy term newborns could reduce the amount of transcutaneous bilirubin.


zinc sulfate, transcutaneous bilirubin, term neonate, jaundice


Namasivayam A, Waldemar AC. Jaundice and hyperbilirubinemia in the newborn. In: kliegman RM, Stanton BF, Schor NF, Geme JW, Behrman RE. Nelson text book of pediatrics. 19th ed. Philadelphia: Saunders. 2011;603-12.

Michael K, Ronald JW, EricSibley DK. Neonatal jaundice and liver disease. In: Martin RJ, Fanaroff AA, Walsh MC. Neonatal-perinatal medicine diseases of the fetus and infant medicine. 9th ed. Philadelphia: Mosby Elsevier. 2011;1443-81 .

American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297-316.

Newman TB, Maisels MJ. Evidence insufficient to recommend melanoma surveillance following phototherapy for jaundice. Arch Dermatol. 2007;143(9):1216.

Matichard E, Le Henanff A, Sanders A, Leguyadec J, Crickx B, Descamps V. Effect of neonatal phototherapy on melanocytic nevus count in children. Arch Dermatol 2006;142(12):1599-604.

Dennery PA, Lorch S. Neonatal blue–light phototherapy could increase the risk of dysplastic nevus development. Pediatrics. 2007;120(1):247-8.

Cuperus FJ, Hafkamp AM, Hulzebos CV, Verkade HJ. Pharmacological therapies for unconjugated hyperbilirubinemia. Curr Pharm Des. 2009;15(25):2927-38.

Vitek L, Muchova L, Zelenka J, Zadinova M, Malina J. The effect of zinc salts on serum bilirubin levels in hyperbilirubinemic rats. J Pediatr Gastroenterol Nutr. 2005;40(2):135-40.

Mendez-Sanchez N, Roldan-Valadez E, Flores MA, Cardenas-Vazquez R, Uribe M. Zinc salts precipitate unconjugated bilirubin in vitro and inhibit enterohepatic cycling of bilirubin in hamsters. Eur J Clin Invest. 2001;31(9):773-80.

Mendez-Sanchez N, Martinez M, Gonzalez V, Roldan-Valadez E, Flores MA, Cardenas-Vazquez R, et al. Zinc sulfate inhibits the enterohepatic cycling of unconjungated bilirubin in subjects with Gilbert´s Syndrome. Ann Hepatol. 2002;1(1):40-3.

Rana N, Mishra S, Bhatnagar S, Paul V, Deorari AK, Agarwal R. Efficacy of zinc in reducing hyperbilirubinemia among at risk neonates: a randomized, double- blind, placebo- controlled trial. Indian J Pediatr. 2011;78(9):1073-8.

Aggett PJ, Comerford JG. Zinc and human health. Nutr Rev. 1995;53(9):16-22.

Brown KH, Rivera JA, Bhutta Z, Gibson RS, King JC, Lönnerdal B, et al. Assessment of the risk of zinc deficiency in populations and options for its control. Food Nutr Bull. 2004;25(1):99-203.

Lamberti LM, Walker CL, Chan KY, Jian WY, Black RE .Oral zinc supplementation for the treatment of acute diarrhea in children: a systematic review and meta-analysis. Nutrients. 2013;5(11):4715-40.

Strand TA, Chandyo RK, Bahl R, Sharma PR, Adhikari RK, Bhandari N, et al. Effectiveness and efficacy of zinc for the treatment of acute diarrhea in young children. Pediatrics. 2002;109(5):898-903.

Bahl R , Bhandari N, Saksena M, Strand T, Kumar GT, Bhan MK, et al. Efficacy of zinc fortified oral rehydration solution in 6 to 35 month old children with acute diarrhea. J Pediatr. 2002;141(5):677-82.

Cario E, Jung S, Harder D’Heureuse J, Schulte C, Sturm A, Wiedenmann B, et al. Effects of exogenous zinc supplementation on intestinal epithelial repair in vitro. Eur J Clin Invest. 2000;30(5):419-28.

Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 1998;68(2):447-63.

Patro B, Golicki D, Szajewska H. Meta-analysis: zinc supplementation for acute gastroenteritis in children. Aliment Pharmacol Ther. 2008;28(6):713-23.

Scrimgeour AG, Lukaski HC. Zinc and diarrheal disease: current status and future perspectives. Curr Opin Clin Nutr Metab Care. 2008;11(6):711-7.

Semmekrot BA, deVries MC, Gerrits GP, van Wieringen PM. Optimal breastfeeding to prevent hyperbilirubinemia in healthy term newborns. NedTijdschr Geneeskd. 2004;148(41):2016-19.

Prashanth GP. The significance of enterohepatic circulation in the causation neonatal hyperbilirubinemia. Indian J Pediatr. 2012;79(9):1251-2.

Chen J, Sadakata M, Ishida M, Sekizuka N, Sayama M. Baby massage ameliorates neonatal jaundice in full-term newborn infants. Tohoku J Exp Med. 2011;223(2):97-102.

DOI: http://dx.doi.org/10.22110/jkums.v17i11.1329


  • There are currently no refbacks.

Copyright (c)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.